MOUNJARO

Mounjaro for type 2 diabetes and obesity

Type 2 diabetes is a metabolic disorder characterized by elevated blood sugar levels, resulting either from insufficient insulin production or inadequate insulin response from cells. This leads to an increase in blood sugar levels that the body can no longer regulate on its own. The active ingredient tirzepatide is a dual receptor agonist for GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). It aims to promote insulin secretion and inhibit glucagon release to improve blood sugar control. Furthermore, tirzepatide delays gastric emptying and increases satiety, which can contribute to weight loss.